New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsin
Reductions in annualized relapse rates shown in pivotal trials with ozanimod...
2018-04-25
文传商讯
Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Exten
Open-label extension of TOUCHSTONE study of ozanimod showed continued sympto...
2016-10-18
文传商讯
Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerativ
In patients with moderate to severe ulcerative colitis, histologic improveme...
2016-03-21
文传商讯
Oral Ozanimod 72-Week Phase 2 Results From RADIANCE Trial in Relapsing
Reductions in brain lesions at week 24 were maintained while relapses were f...
2016-02-21
文传商讯
